Active	Status	Sponsor type	Region	Phase	Filter
4 Active 19 Inactive 23 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Clark, Gary F
NCT06122766: NGLY1 Natural History	Recruiting	N/A	15	US		Baylor College of Medicine, Grace Science Foundation	NGLY1 Deficiency	02/25	02/25
NCT04476862: Cerliponase Alfa Observational Study in the US	Active, not recruiting	N/A	35	US	Cerliponase Alfa, Brineura, Administration Kit	BioMarin Pharmaceutical	Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2	08/30	08/30
Heptulla, Rubina
NCT00923715: Exenatide (Byetta) Versus Pramlintide (Symlin): Role in Post-Prandial Hyperglycemia	Enrolling by invitation	3	63	US	Insulin, Insulin and Exenatide, Insulin and Pramlintide	Baylor College of Medicine, Albert Einstein College of Medicine of Yeshiva University	Diabetes Mellitus, Type 1	12/11	05/12
NCT03005951: The Influence of Breakfast on Hormone Responses and Cognitive Performance	Completed	N/A	17	US	A= Yes Breakfast, B=No Breakfast	Albert Einstein College of Medicine, New York State Department of Health, Montefiore Medical Center	Insulin Resistance	01/19	01/19